跳至主要内容
临床试验/CTRI/2024/09/074440
CTRI/2024/09/074440已完成不适用

Effectiveness of Extracorporeal Shockwave Therapy versus Complex Decongestive Therapy in Breast Cancer Related Lymphedema: A Single Blinded Randomized Controlled Trial

KLE Academy of Higher Education and Research1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2024年10月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Arm circumference using measuring tape. Shoulder pain and disability using Shoulder pain and Disability Index

研究概览

简要总结

Effectiveness of Extracorporeal Shockwave Therapy Versus Complex Decongestive Therapy in Breast Cancer-Related Lymphedema: A Single-Blinded Randomized Controlled Trial

Aim of Study: To compare the effectiveness of Extracorporeal Shockwave Therapy Versus Complex Decongestive Therapy for Breast Cancer-Related Lymphedema

Null Hypothesis: There will be no significant difference between the effect of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy in terms of arm circumference, shoulder pain and disability, hand grip strength, quality of life and neuropathic symptoms in particpants with breast cancer related lymphedema.

Alternate hypothesis: There will be significant difference between the effect of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy in terms of arm circumference, shoulder pain and disability, hand grip strength, quality of life and neuropathic symptoms in particpants with breast cancer related lymphedema.

Inclusion Criteria: 1. All referred cases of Breast cancer patients with lymphedema, aged 18 years and above 2. Lymphedema secondary to breast cancer treatment 3. Unilateral lymphedema

Exclusion criteria: 1. Metastatic cancer 2. Active leukemia 3. Acute inflammation and infection 4. Severe trauma or disruptive surgery to arm 5. Pregnancy, Breast feeding 6. Previously undergone CDT or any form of physical therapy within 3 months

A written informed consent will be obtained from the participants. A brief demographic data will be obtained from the subjects prior to assessment. Baseline assessment of the particpants will be done before the intervention. Then the particpants will be divided into two groups i.e. Extracorporeal Shockwave Therapy group (n=11) and Complex Decongestive Therapy group (n=11). Both groups will be treated 3 times a week for 3 weeks and data will be collected and analysed.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 85.00 Year(s)(—)
性别
Female

入选标准

  • All referred cases of breast cancer patients with lymphedema, aged 18 years and above
  • Lymphedema secondary to breast cancer treatment
  • Unilateral lymphedema.

排除标准

  • Metastatic cancer
  • Active leukemia
  • Acute inflammation and infection
  • Severe trauma or disruptive surgery to arm
  • Pregnancy/Breast feeding
  • Previously undergone Complex Decongestive Therapy or any form of physical therapy within 3 months.

结局指标

主要结局

Arm circumference using measuring tape. Shoulder pain and disability using Shoulder pain and Disability Index

时间窗: Pre- Baseline | Post- after 1, 2 and 3 weeks

次要结局

  • Hand grip strength using Dynamometer, Quality of life by using Functional Assessment of Cancer Therapy Breast (FACT-B) and Neuropathic symptoms by using Functional Assessment of Cancer Therapy/Gynaecologic Oncology-Neurotoxicity (FACT-GOG NTx)(Pre- Baseline)

研究者

发起方
KLE Academy of Higher Education and Research
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Asmita Shrestha

KAHER Institute of Physiotherapy

研究点 (1)

Loading locations...

相似试验